Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Dose Escalation Study of Proton and Carbon Ion Irradiation for HER2 Positive and Triple Negative Breast Cancer After Breast Conserving Surgery

NCT05692661 is registered in ClinicalTrials.gov with Shanghai Proton and Heavy Ion Center as lead sponsor.

NCT NCT05692661
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05692661 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Dose Escalation Study of Proton and Carbon Ion Irradiation for HER2 Positive and Triple Negative Breast Cancer After Breast Conserving Surgery
Lead sponsor
Shanghai Proton and Heavy Ion Center
Phase
Phase 1
Overall status
Unknown status
Start date
January 10, 2023
Completion date
January 10, 2026
Enrollment
24 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

her2-positive breast cancer, triple negative breast cancer